Algernon Pharmaceuticals Inc.
Algernon Pharmaceuticals is a drug re-purposing company that investigates safe, already approved drugs for new disease applications, moving them efficiently and safely into new human trials, developing new formulations and seeking new regulatory approvals in global markets. Algernon specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off label prescription writing.
Algernon Pharmaceuticals Inc. (AGN)
le 21 avril/April 2023
Algernon Pharmaceuticals Inc. Rights listed on March 28, 2023 will expire on April 27, 2023.
Settlement Terms: All trades April 25 and 26 will be for cash next day settlement. Trades on April 27 will be for cash same day.
The rights will be halted at noon and delisted at market close April 27, 2023.